Related content

Neutralising antibodies to interferon β in multiple sclerosis: Expert panel report

By Hartung H.-P.   Polman C.   Bertolotto A.   Deisenhammer F.   Giovannoni G.   Havrdova E.   Hemmer B.   Hillert J.   Kappos L.   Kieseier B.   Killestein J.   Malcus C.   Comabella M.   Pachner A.   Schellekens H.   Sellebjerg F.   Selmaj K.   Sorensen P.  

Journal of Neurology, Vol. 254, Iss. 7, 2007-07 ,pp. : 827-837

Springer Publishing Company

Access to resources Recommend Favorite

Anti-phospholipid antibodies are associated with response to interferon-beta1a treatment in MS: results from a 3-year longitudinal study

By Zivadinov Robert   Ramanathan Murali   Ambrus Julian   Hussein Sara   Ramasamy Deepa P   Dwyer Michael G   Bergsland Niels   Minagar Alireza   Weinstock-Guttman Bianca  

Neurological Research, Vol. 34, Iss. 8, 2012-10 ,pp. : 761-769

Maney Publishing

Access to resources Recommend Favorite

Plasma ubiquitin-proteasome system profile in patients with multiple sclerosis: correlation with clinical features, neuroimaging, and treatment with interferon-beta-1b

By Minagar Alireza   Ma Wanlong   Zhang Xi   Wang Xiuqiang   Zhang Ke   Alexander J Steven   Gonzalez-Toledo Eduardo   Albitar Maher  

Neurological Research, Vol. 34, Iss. 6, 2012-07 ,pp. : 611-618

Maney Publishing

Access to resources Recommend Favorite

Atheromatosis Extent in Coronary Artery Disease is not Correlated with Apolipoprotein-E Polymorphism and its Plasma Levels, but Associated with Cognitive Decline

By  

Current Alzheimer Research, Vol. 7, Iss. 6, 2010-09 ,pp. : 556-563

Bentham Science Publishers

Access to resources Recommend Favorite

Interferon-beta or azathioprine as add-on therapies in patients with active multiple sclerosis

By Ticha Veronika   Kalincik Tomas   Havrdova Eva  

Neurological Research, Vol. 34, Iss. 10, 2012-12 ,pp. : 923-930

Maney Publishing

Access to resources Recommend Favorite